Skip to content
Disclosery

ABG-WTT Global Life Science Capital Partners GP Ltd

Follow

13F filer, CIK 1832108, CENTRAL, HONG KONG, Hong Kong

ABG-WTT Global Life Science Capital Partners GP Ltd reported $18,675,589 across 2 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001193125-25-283037

Period
2025-09-30
Reported value
$18.7M
Holdings
2
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001193125-25-283037, largest first. % of portfolio is the value over $18,675,589, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CBLLCERIBELL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 1,088,101 shares; 2025Q1: 1,088,101 shares; 2025Q2: 1,088,101 shares; 2025Q3: 1,088,101 shares 1,088,101$12.5M66.94%0Timeline
RPIDRAPID MICRO BIOSYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,038,296 shares; 2024Q4: 1,038,296 shares; 2025Q1: 1,848,296 shares; 2025Q2: 1,848,296 shares; 2025Q3: 1,848,296 shares 1,848,296$6.17M33.06%0Timeline

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001193125-25-283037 base2025-11-14acceptance time not in the bulk data set